Kemwell Biopharma is a biologics contract development and manufacturing organization (CDMO) based in Bangalore, Karnataka, India. The company specializes in mammalian cell culture process development and offers extensive mammalian cell culture-based product development services. Kemwell has a cGMP facility and aims to become India's first biologics CMO with USFDA approval. It also provides integrated development and manufacturing services for companies that require a one-stop solution for mammalian cell-culture based protein therapeutics. The company has a joint venture with Cipla Limited to develop, manufacture, and commercialize biosimilars for global markets. Kemwell is also working on technologies like fusion proteins for novel biologics and has set up a cGMP cell therapy plant. Kemwell Biopharma is focused on becoming a global leader and first-choice CDMO for biologics.
Legal Address
Kemwell House No.11, Tumkur Road
Bangalore; Karnataka;
Postal Code: 560022
Contact Details: Purchase the Kemwell Biopharma Private Limited report to view the information.
Website: http://www.kemwellbiopharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service